KIMBERLINA HARVEY: Open Payments
NPI 1699348292 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 51 payments from 8 companies in 2025. Trend: 2023 $124 · 2024 $155 · 2025 $935
Food & beverage: $884Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $224 |
| ABBVIE INC. | 16 | $218 |
| Madrigal Pharmaceuticals | 8 | $195 |
| Lilly USA, LLC | 4 | $86 |
| Aimmune Therapeutics, Inc. | 3 | $85 |
| CORDIS US CORP. | 3 | $81 |
| PFIZER INC. | 2 | $32 |
| QOL Medical, LLC | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, LINZESS, OMVOH, MYNX CONTROL VENOUS, VOWST, MAVYRET, RINVOQ.
Industry payments across NV — which companies pay providers there.
